Table 1 Clinicopathological characteristics of patients

Total

49

Sex

 Male/female

32/17

Blood type

 Compatible/incompatible

38/11

Donor-specific anti-HLA Ab

 Positive/negative

10/39

Rituximab

 Yes/no

18/31

Donor type

 Living/deceased

46/3

Reason for biopsy

 Protocol/episode

25/24

Number of biopsies

 1

13

 2

10

 3

4

 4

1

Pathological diagnosis

 Normal

29

 Acute T cell-mediated rejection

11

 Antibody-mediated rejection

1

 Interstitial fibrosis/tubular atrophy

3

 BK virus nephropathy

3

 Calcineurin inhibitor nephropathy

1

 Thrombotic microangiopathy

1

Diabetes

 Yes/no

14/35

DPP-4 inhibitor

 Yes/no

4/10

Immunosuppressives

 Tac + MMF + MP

33

 CyA + MZ + MP

4

 CyA + MMF + MP

3

 Tac + MMF + MP + EVL

2

 Tac + MZ + MP

2

 Tac + MMF

2

 Tac + EVL + MP

1

 CyA + MP

1

 Tac + EVL

1

Median age

48 (20–73) y

Median elapsed time after transplantation

11 (0–52) m